DIM
PAHC icon

DC Investments Management’s Phibro Animal Health PAHC Stock Holding History

DC Investments Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,966
Closed -$200K – 313
2017
Q4 		$200K Buy
+5,966
New +$212K 0.08% 297

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CRCP
Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DC Investments Management's PAHC Position: Q1 2018 in Review

DC Investments Management sold out of Phibro Animal Health (PAHC) in Q1 2018, closing a stake of 5,966 shares — an estimated $200K sold.

DC Investments Management first reported a position in PAHC in Q4 2017 and held it in 1 quarter. The position peaked at $200K in Q4 2017. 171 funds tracked by Wall St. Rank hold PAHC as of Q1 2018.

  • DC Investments Management reported no remaining Phibro Animal Health position as of Q1 2018 after selling out during the quarter.
  • DC Investments Management sold 5,966 Phibro Animal Health shares in Q1 2018, an estimated $200K.
  • DC Investments Management first reported a position in Phibro Animal Health in Q4 2017 and held it in 1 quarter.
  • DC Investments Management's Phibro Animal Health position peaked at $200K in Q4 2017.
  • 171 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2018.

Based on DC Investments Management's 13F filing for Q1 2018, filed 2 May 2018.